Susan Y. Chon
Department of Dermatology, Division of Internal Medicine
Education & Training
Degree-Granting Education
| 1997 | Stanford University School of Medicine, Stanford, California, US, Medicine, Doctor of Medicine |
| 1991 | Brown University, Providence, Rhode Island, US, Literature, Bachelor of Arts with Honors |
Postgraduate Training
| 1998-2001 | Clinical Residency, Stanford University, Stanford, California |
| 1997-1998 | Clinical Internship, Stanford University, Stanford, California |
Licenses & Certifications
| 2004 | Texas Medical License |
| 2001 | American Board of Dermatology |
Experience & Service
Faculty Academic Appointments
Associate Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2018
Assistant Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2012
Assistant Professor, Division of Dermatology, UCLA, Los Angeles, CA, 2003 - 2004
Staff Physician, Department of Dermatology, Kaiser Permanente Redwood City, Redwood City, CA, 2001 - 2003
Clinical Instructor, Department of Dermatology, Stanford University, Stanford, CA, 2001 - 2003
Other Professional Positions
Research fellow Supervisor: Dr. Suephy Chen, Research subjects: 1) Meta-Analysis of Methotrexate Use in Psoriasis, 2) Quality of Life Outcomes in Patients with Rosacea, Stanford University, Department of Dermatology, Stanford, CA, 1999 - 2001
Research fellow Supervisor: Dr. Charles Prober, Research subject: T cell response to type specific HSV 2 glycoproteins using Western blot, ELISA, and cell-mediated immunity assays, Stanford University, Department of Pediatric Infectious Diseases, Stanford, CA, 1993 - 1995
Clinical research fellow Supervisor: Drs. Peter Wiest, Stephen McGarvey, & Wu Guan Ling, Res. subjects:1)Impact of annual screening and chemo on schistosomiasis on Ji Shan Island, 2)Child growth & nutritional status Jiang Xi, Sichuan Province Institute of, Chengdu Jiangsu Province Hospital Department of Infectious Diseases, Chendu, 1991 - 1993
Intramural Institutional Committee Activities
Member, Clinical Faculty Review Committee-Appointments (CFRC-A), The University of Texas MD Anderson Cancer Center, 2025 - 2026
Extramural Institutional Committee Activities
Member, Dermatology Representative, Clinical Effectiveness Subcommittee, The University of Texas MD Anderson Cancer Center, 2014 - 2017
Member, Faculty Health and Well Being Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present
Committee Member, Clinical Research Committee (CRC3, The University of Texas MD Anderson Cancer Center, 2011 - Present
Quality Officer for the Department of Dermatology, OPPE/FPPE Quality Committee, The University of Texas MD Anderson Cancer Center, 2009 - Present
Committee Member, Clinical Research Committee (CRC4), The University of Texas MD Anderson Cancer Center, 2009 - 2011
Member, DoIM Quality Council, The University of Texas MD Anderson Cancer Center, 2006 - Present
Member, Survivorship Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2008
Member, Resource Development Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2008
Member, DoIM Research Committee, The University of Texas MD Anderson Cancer Center, 2005 - Present
Committee member, Melanoma SPORE Advisory Board, The University of Texas MD Anderson Cancer Center, 2005 - 2009
Member, Diversity Committee, The University of Texas MD Anderson Cancer Center, 2004 - 2009
Member, Cultural Principles Working Group - Focus group, The University of Texas MD Anderson Cancer Center, 2004 - 2008
Honors & Awards
| 2022 | GOLD award in Video-Digital Health Awards, Health Information Resource Center |
| 2022 | SILVER Award in Video-Digital Health Awards, Health Information Resource Center |
| 2021 | The Division of Internal Medicine Excellence Award Nominee in Quality, The University of Texas MD Anderson Cancer Center |
| 2007 | Early Career Women Faculty Development Award, AAMC |
| 2006 - 2007 | NIH Loan Repayment Award |
| 2001 | National Research Service Award in Health Services Research |
| 2000 | Women's Dermatology Society Mentorship Grant |
| 1999 | Dermatology Resident Educational Grant, Skin Disease Education Foundation |
| 1999 | Excellence in Medical Student Teaching |
| 1995 | Excellence in Research Award, American Federation for Clinical Research |
| 1995 | MacKenzie Scholarship for Independent Research |
| 1995 | Outstanding Paper in Infectious Diseases, American Federation for Clinical Research |
| 1994 | Chinese Hospital of San Francisco Clinical Research Grant, Chinese Hospital of San Francisco |
| 1993 | Partnership for Child Development Scholar of the Imperial College of London |
| 1991 | Bowman Scholar, Brown University Research Grant |
| 1990 | Ford Foundation Grant |
| 1990 | Undergraduate Teaching and Research Assistant Grant, Psychology Department |
| 1990 | Resource Scholar- Undergraduate Honors Thesis |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2023. Women Leading the Evolution of Skincare. Conference. Bank of America Women's Leadership Series. Houston, TX, US.
- 2023. Needlestick Safety. Conference. The University of Texas Health Science Center. Houston, TX, US.
- 2022. Decreasing the no show rate in the CPC Dermatology Clinic. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2021. Decreasing the Incidence of Inpatient Dermatology Pathology Specimen Processing Errors. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2020. Vitamin D: What you need to know. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2020. Morphological Reaction Patterns. Conference. The University of Texas Health Science Center. Houston, TX, US.
- 2020. Pathological Basis of Skin Cancer and Melanoma. Conference. Baylor College of Medicine. Houston, TX, US.
- 2020. QI Project-Needlestick Safety and Prevention. Conference. The University of Texas Health Science Center. Houston, TX, US.
- 2017. Decreasing Error in Specimen labeling in EPIC. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2015. Decreasing the Incidence of Needle Sticks in Dermatology Procedures. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2014. Decreasing the Incidence of Needle sticks in Dermatology Procedures. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2013. Decreasing the cost of Dermatological Procedures. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2013. Early Detection and Screening. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2012. Decreasing Error in Specimen labeling in Dermatology. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2011. Update on Skin Cancer and Prevention. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2010. Quality Improvement Initiative in the Division of Internal Medicine. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2010. Dermatology Issues in Cancer Patients. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2010. Skin Cancer. Conference. The El Paso Corporation. Houston, TX, US.
Regional Presentations
- 2023. Texas Dermatological Society Resident Podium Presentations. Conference. Texas Dermatological Society. San Antonio, TX, US.
- 2011. Most Common Dermatoses Seen in Primary Care. Conference. Citizens Medical Center. Victoria, TX, US.
- 2010. Improving the Accuracy in Dermatology Specimen Labeling. Conference. The University of Texas System Clinical Safety and Effectiveness Conference. Austin, TX, US.
National Presentations
- 2013. Treatment of Vemurafenib-Related Cutaneous Side Effects with Acitretin. Conference. 71st Annual Meeting of the American Academy of Dermatology. Miami, FL, US.
International Presentations
- 2011. Skin Cancer and Sarcomas. Invited. BIT Life Sciences’ 4th World Cancer Congress (WCC), CN.
- 2010. Skin Cancer and Sarcomas. Invited. BIT Life Sciences’ 3rd World Cancer Congress (WCC), SG.
Formal Peers
- 2013. Sun Damage and Skin Cancer Prevention. Visiting. Brookshire, TX, US.
- 2009. Dermatologic Manifestations of Targeted Therapies in Cancer Patients. Visiting. Albuquerque, NM, US.
- 2008. Superficial Science of EGFR Inhibitors: Addressing Skin Toxicities. Visiting. Houston, TX, US.
- 2008. Challenges of treating side effects of EGFR inhibitors. Invited. St. Paul, MN, US.
- 2008. Challenges of treating side effects of EGFR inhibitors. Invited, AL, US.
- 2008. Tumor Board. Visiting. Winston, NC, US.
- 2008. Treatment of EGFRI Skin Eruptions. Visiting. Greensboro, NC, US.
- 2008. EGFR Inhibitors & Skin Toxicities. Invited. Dallas, TX, US.
- 2008. EGFR Inhibitors & Skin Toxicities. Invited. Las Vegas, NV, US.
- 2008. EGFR Inhibitors & Skin Toxicities. Invited. Beaumont, TX, US.
- 2008. Dermatologic Manifestations of Targeted Therapies in Cancer Patients. Invited, AL, US.
- 2008. Update on EGFR Toxicities & Side Effects. Visiting, UT, US.
Grant & Contract Support
| Title: | Be Seen on the Green: Skin Cancer Screening in College Students on Campus |
| Funding Source: | Doss Foundation |
| Role: | PI |
| Title: | Logistical design and implementation of a distance based video/audio transcription system |
| Funding Source: | American Academy of Dermatology |
| Role: | Principal Investigator-MDACC |
Selected Publications
Peer-Reviewed Articles
- Sohail N, Sohail A, Alsaidi A, Zamil D, Chon SY. Non-Tobacco Nicotine Dependence and Rates of Postoperative Complications in Basal Cell Carcinoma: A Retrospective Analysis. Clin Exp Dermatol 51(6):1117-1119, 2026. e-Pub 2026. PMID: 41622033.
- George MN, Seervai RNH, Chon SY. Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series. JAAD Case Rep 47:72-79, 2024. e-Pub 2024. PMID: 38659476.
- Yun YR, Choi YJ, Kim YS, Chon SY, Lee MA, Chung YB, Park SH, Min SG, Yang HC, Seo HY. Antioxidant and anti-inflammatory effects of solar salt brined kimchi. Food Sci Biotechnol 32(5):679-687, 2023. e-Pub 2023. PMID: 37009041.
- Lee MA, Choi YJ, Kim YS, Chon SY, Chung YB, Park SH, Yun YR, Min SG, Yang HC, Seo HY. Effects of salt type on the metabolites and microbial community in kimchi fermentation. Heliyon 8(11):e11360, 2022. e-Pub 2022. PMID: 36387467.
- Patel AB, Farooq S, Welborn M, Amaria RN, Chon SY, Diab A, Glitza Oliva IC, Huen AO, Li SQ, Nelson KC, Pacha O, Patel SP, Rapini RP, Tawbi HA, Wong MK, McQuade J, Davies MA, Haydu LE. Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit. Cancer 128(5):975-983, 2022. e-Pub 2022. PMID: 34724197.
- Lee KP, Girijala RL, Chon SY. Phytophotodermatitis due to a Citrus-Based Hand Sanitizer: A Case Report. Korean J Fam Med 43(4):271-273, 2022. e-Pub 2022. PMID: 35903051.
- Hwang IS, Chon SY, Bang WS, Kim MK. Influence of Roasting Temperatures on the Antioxidant Properties, β-Glucan Content, and Volatile Flavor Profiles of Shiitake Mushroom. Foods 10(1), 2020. e-Pub 2020. PMID: 33379207.
- Wiggins CJ, Chon SY. Anti-CTLA-4 therapy-associated granuloma annulare in chronic myelomonocytic leukemia. Proc (Bayl Univ Med Cent) 34(1):122-123, 2020. e-Pub 2020. PMID: 33456170.
- Wiggins CJ, Chon SY. Dermatomyositis, pembrolizumab, and squamous cell carcinoma of the lung. Proc (Bayl Univ Med Cent) 34(1):120-121, 2020. e-Pub 2020. PMID: 33456169.
- Wiggins CJ, Chon SY. Vancomycin-induced linear IgA bullous dermatosis. Proc (Bayl Univ Med Cent) 34(1):83-84, 2020. e-Pub 2020. PMID: 33456152.
- Sallman MA, Li JY, Swaby M, Chon SY. Cutaneous Scalp Metastasis of Cholangiocarcinoma in Hepatitis C. JAAD Case Rep 6(5):468-470, 2020. e-Pub 2020. PMID: 32395602.
- Bush AE, Garcia A, Li J, Curry J, Chon SY. CD30+ lymphomatoid skin toxicity secondary to ipilimumab. JAAD Case Rep 6(4):251-253, 2020. e-Pub 2020. PMID: 32211493.
- Wiggins CJ, Chon SY. Cutaneous Effects of Notch Inhibitor Therapy: A Report of Two Cases. Case Rep Dermatol Med 2020:8842242, 2020. e-Pub 2020. PMID: 32695530.
- Aria AB, Chen L, Glass WF, Lahoti A, Chon SY. Leukocytoclastic vasculitis with late-onset Henoch-Schönlein purpura after trifluridine/tipiracil treatment. Dermatol Online J 24(10), 2018. e-Pub 2018. PMID: 30677817.
- Aria AB, Chen L, Torres-Cabala CA, Chon SY. Chronic granulomatous reaction in patients receiving vaccine immunotherapy for metastatic melanoma. JAAD Case Rep 4(1):87-90, 2018. e-Pub 2018. PMID: 29379857.
- Lopez Pineiro M, Willis E, Yao C, Chon SY. Pyoderma gangrenosum-like ulceration of the lower extremity secondary to sunitinib therapy: a case report. SAGE Open Med Case Rep 6:2050313X18783048, 2018. e-Pub 2018. PMID: 29977559.
- Tetzlaff MT, Nagarajan P, Chon S, Huen A, Diab A, Omar P, Aung PP, Torres-Cabala CA, Mays SR, Prieto VG, Curry JL. Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features. Am J Dermatopathol 39(2):121-129, 2017. e-Pub 2017. PMID: 28134729.
- Pinney SS, Jahan-Tigh RR, Chon S. Generalized eruptive histiocytosis associated with a novel fusion in LMNA-NTRK1. Dermatol Online J 22(8), 2016. e-Pub 2016. PMID: 27617936.
- Chon SY, Hassler AA. Demodex inflammatory eruption due to epidermal growth factor receptor inhibitor therapy. Br J Dermatol 174(3):686-7, 2016. e-Pub 2016. PMID: 26719099.
Review Articles
- Baig, IT, Petronzio, A, Maphet, B, Chon, S. A Review of the Impact of Sun Safety Interventions in Children. Dermatology Practical and Conceptual 13(1), 2023. e-Pub 2023. PMID: 36892334.
- Curry JL, Chon SY, Marques-Piubelli ML, Chu EY. Cutaneous Toxicities in the Setting of Immune Checkpoint Blockade:: The Era of Oncodermatopathology. Surg Pathol Clin 14(2):209-224, 2021. e-Pub 2021. PMID: 34023101.
Professional Educational Materials
- Richards K, Hassler A, Chon SY. Demodex Inflammatory Eruption Due to EGFR Inhibitor Therapy, 2013.
- Singh L, Bicknell L, Daulat S, Diaz L, Chon SY, Ciurea A, Hymes S. Development of New Melanomas and Atypia in Pre-existing Nevi in Patients Undergoing BRAF-Inhibitor Therapy, 2013.
- Pickett M, Chon SY. Decreasing Procedure Cost: Are Biopsy Kits Effective?, 2013.
- Efron-Everett M, Pickett M, Chon SY. Furuncular Myiasis in a Traveler to Belize, 2013.
- Chon SY. EGFR Inhibitor Skin Eruptions: Diagnosis and Treatment, 2007.
Book Chapters
- Duvic, M, Chon, S. Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases. In: Goldman-Cecil Medicine, 2724-2738.e1, 2023.
- Hui D. Dermatology. In: Approach to Internal Medicine. Third. Springer, 361-376, 2011.
- Hymes S, Chon SY, Ciurea A. Skin Disorders Difficult to Distinguish from Infections. In: Principles and Practice of Cancer Infectious Diseases, 2011.
Books (edited and written)
- Chon SY. Children's Book - Promoting Skin Cancer Prevention and Awareness.
Patient Reviews
CV information above last modified August 18, 2026